Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Monoclonal Anti-IL6 Antibody (Tocilizumab) on the Cardiovascular Risk in Patients With Rheumatoid Arthritis

NCT01752335 is registered in ClinicalTrials.gov with Hospital Universitario de Canarias as lead sponsor.

NCT NCT01752335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01752335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Monoclonal Anti-IL6 Antibody (Tocilizumab) on the Cardiovascular Risk in Patients With Rheumatoid Arthritis
Lead sponsor
Hospital Universitario de Canarias
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2011
Completion date
March 31, 2017
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis